Trial · NCT07902310
Effects of Contralateral Gravity Eliminated Gluteus Medius and Ipsilateral Quadratus Lumborum Strengthening on Pelvic Alignment, Balance and Functional Mobility on Subacute Stroke Patients
NCT07902310, Not applicable, Recruiting, Lahore University of Biological and Applied Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Contralateral Gravity Eliminated Gluteus Medius and Ipsilateral Quadratus Lumborum Strengthening on Pelvic Alignment, Balance and Functional Mobility on Subacute Stroke Patients. Trials, record NCT07902310. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902310
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Contralateral Gravity Eliminated Gluteus Medius and Ipsilateral Quadratus Lumborum Strengthening on Pelvic Alignment, Balance and Functional Mobility on Subacute Stroke Patients
- NCT number
- NCT07902310
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Lahore University of Biological and Applied Sciences
- Conditions
- Stroke
- Interventions
- Contralateral Gravity-Eliminated Gluteus Medius Strengthening, Quadratus Lumborum Strengthening Group, Conventional Physiotherapy
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pelvic Alignment (PALM) | Baseline, immediately after the 6-week intervention (Week 6), and at Week 12 follow-up. | Pelvic alignment will be assessed using the Palpation Meter (PALM), which measures pelvic inclination in degrees using standardized positioning and palpation of relevant pelvic landmarks. Changes in pelvic tilt will be evaluated to determine the effects of contralateral gravity-eliminated gluteus medius strengthening and ipsilateral quadratus lumborum strengthening combined with conventional physiotherapy. |
| Primary | Berg Balance Scale (BBS) | Baseline, immediately after the 6-week intervention (Week 6), and at Week 12 follow-up. | Functional balance will be assessed using the Berg Balance Scale (BBS), which consists of 14 functional tasks, each scored from 0 to 4, with a maximum total score of 56. Higher scores indicate better balance performance. Changes in total BBS scores will be compared between the two intervention groups to evaluate improvements in functional balance. |
| Primary | Timed Up and Go (TUG) | Baseline, immediately after the 6-week intervention (Week 6), and at Week 12 follow-up. | Functional mobility will be assessed using the Timed Up and Go (TUG) test. Participants will be instructed to stand up from a chair, walk 3 metres, turn around, return to the chair, and sit down. The time required to complete the test will be recorded in seconds. A shorter completion time indicates better functional mobility. Changes in TUG completion time will be compared between the two intervention groups. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902310
GET https://conductscience.org/api/trials/v1/NCT07902310/registered